Replies to post #99615 on Avid Bioservices Inc (CDMO)

[corporalagarn]

I'm tempted to sell the rest and buy back later, but I'm too chicken, or stupid.

Seriously, what, other than dilution is news here?

Avid is doing well, but not well enough to support the company.

A bunch of IST's? we knew that.

Data is forthcoming in some of the other trials that don't have major discrepancies? Will people believe the results.

In talks regarding Cotara? Must be getting a sore throat at this point.